Insider planned share sales for CLOV (CLOV) disclosed in filing Form 144

Rhea-AI Filing Summary

An insider of CLOV has filed a Form 144 indicating an intent to sell 2,102 shares of common stock through broker Morgan Stanley Smith Barney LLC on or about January 7, 2026 on the NASDAQ. These shares were acquired on January 3, 2026 as restricted stock units from the issuer. The filing notes that 424,304,898 common shares were outstanding. Over the prior three months, the same seller completed additional common stock sales labeled as “10b5-1 Sales”.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2102	5444.18	424304898	01/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/03/2026	Restricted Stock Units	Issuer			2102	01/03/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	12/18/2025	4913	12813.60
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	11/04/2025	30385	108854.26
10b5-1 Sales for JAMIE REYNOSO 1209 Orange Street Wilmington DE 19801	Common	10/17/2025	16514	44376.42

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many CLOV shares are covered by this Form 144 notice?

The Form 144 reports a planned sale of 2,102 shares of common stock for CLOV through Morgan Stanley Smith Barney LLC.

When were the CLOV shares to be sold under Form 144 acquired and how?

The 2,102 shares to be sold were acquired on January 3, 2026 as restricted stock units from the issuer.

What is the recent selling history for this CLOV insider under 10b5-1?

The filing lists 10b5-1 Sales for JAMIE REYNOSO of 4,913 shares on December 18, 2025, 30,385 shares on November 4, 2025, and 16,514 shares on October 17, 2025, all in common stock.

What gross proceeds were reported from recent CLOV stock sales?

The Form 144 reports gross proceeds of $12,813.60 on December 18, 2025, $108,854.26 on November 4, 2025, and $44,376.42 on October 17, 2025 from common stock sales.

On which exchange and around what date is the new CLOV sale expected?

The planned sale of 2,102 CLOV common shares is noted with an approximate sale date of January 7, 2026 and names the NASDAQ as the securities exchange.

How many CLOV common shares were outstanding according to this Form 144?

The filing states that the number of common shares outstanding was 424,304,898 at the time of the notice.

What representation does the CLOV insider make by signing the Form 144?

By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.